APA (7th ed.) Citation

Hermine, O., Gros, L., Tran, T., Loussaief, L., Flosseau, K., Moussy, A., . . . Vermersch, P. Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Hermine, Olivier, Laurent Gros, Truong-An Tran, Lamya Loussaief, Kathleen Flosseau, Alain Moussy, Colin D. Mansfield, and Patrick Vermersch. Tyrosine Kinase Inhibitor, Masitinib, Limits Neuronal Damage, as Measured by Serum Neurofilament Light Chain Concentration in a Model of Neuroimmune-driven Neurodegenerative Disease. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Hermine, Olivier, et al. Tyrosine Kinase Inhibitor, Masitinib, Limits Neuronal Damage, as Measured by Serum Neurofilament Light Chain Concentration in a Model of Neuroimmune-driven Neurodegenerative Disease. Public Library of Science (PLoS).